The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Gene Therapy for Rare Disorders USA 2022
March 7-9, 2022
We hope you enjoyed the Gene Therapy for Rare Disorders USA 2022 event
Our subject matter expert presented on standardizing process characterization for AAV-based vaccine manufacturing. Highlights included:
- Top tips on how to establish an effective standardized Process Characterization program
- Utilizing qualified Scale Down Models (SDMs), an imperative part of biologics licensure applications
- Defining a Process Control Strategy for the product’s journey from early access to clinics to commercial manufacturing
Should we have missed out on connecting at Gene Therapy for Rare Disorders USA 2022, reach out to us to find out more about how we help pharma and new and emerging biotech companies turn pharmaceutical possibilities into realities and get to market faster.